Drug Absorption Flashcards

1
Q

Bioavailability

A

Fraction of unchanged drug that reaches the systemic circulation
IV injection gives 100% bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bioequivalence

A

Generics vs therapeutic substitutions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Generics must have a bioavailability of

A

80-125% compared to the reference product (EU reg.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Generic substitution

A

when a different formulation of the same drug is substituted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Therapeutic substitution

A

the replacement of the originally-prescribed drug with an alternative molecule with assumed equivalent therapeutic effect. The alternative drug may be within the same class or from another class with assumed therapeutic equivalence.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Advantages of oral route

A

– Cheap
– Safe
– Convenient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

disadvantages of oral route

A

– Patient compliance

– Variation in bioavailability of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Journey of an oral drug

A
oral dose
destroyed in gut 
not absorbed 
destroyed by gut wall 
destroyed by liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Buccal / sublingual mucosa

A

– Direct absorption in to bloodstream
– Avoids first pass metabolism
– Not ideal surface for absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Gastric mucosa

A

– Enteric coating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Small intestine

A

– Main site of drug absorption

– Large surface area, more neutral pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Large intestine / colon

A

– Poor absorption, long transit times

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

rectal mucosa

A
  • direct to systemic circulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Four ways small molecules cross cell membranes

A
  1. diffusing directly though the lipid
    - lipid solubility is important
  2. diffusing through aqueous pores
    - more likely for diffusion of gases
  3. transmembrane carrier protein
    - solute carriers
  4. pinocytosis
    - mostly macromolecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Weak bases

A

– Ionised in acidic pH

– Absorbed in small intestine – Ionisation in plasma?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Weak acids

A

– Unionised in acidic pH
– BUT also absorbed in small
intestine
• Large surface area

17
Q

what is the general rule when it comes to food and drug absorption

A

slows down the rate of gastric emptying

18
Q

why would food cause decreased absorption

A

intestinal motility

interactions with food, acids and presystemic metabolism

19
Q

why would food delay absorption

A

gastric emptying, Cmax may be decreased (maximum concentration that a drug achieves in tested area after the drug has been administrated)

20
Q

why would food cause increased absorption

A

poorly water soluble drugs

  • increased solubilisation
  • decreased presystemic metabolism
21
Q

what things should you consider when thinking about the interaction between drugs and food

A

is the drug an irritant?

  • solid vs liquid
  • protein and fat content
  • other dietary factors
22
Q

Levodopa uptake

A
  • Prodrug, treatment of Parkinson’s disease
  • Rapidly taken up from stomach and small intestine by LNAA transport carrier
  • HOWEVER DOPA decarboxylase is present in the gastric mucosa and this causes the DOPA > dopamine reaction and then dopamine is hydrolysed and doesn’t last long so this medication is normally taken with something which inhibits this enzyme
23
Q

Altered rate of drug absorption due to disease state

A
increased = crohns 
decreased = coeliac disease
24
Q

factors that affect oral absorption

A

Particle size and formulation
GI motility
First pass metabolism
– First pass metabolism by gut wall or hepatic enzymes Physicochemical factors
– Direct drug interactions, dietary factors, varying pH

25
Q

Subcutaneous

A

– Slow absorption due to blood flow

26
Q

Intramuscular

A

– Lipophilic drugs rapidly
– Polar drugs via bulk flow and endothelial cell junctions
– High MWT or very lipophobic drugs via lymphatics

27
Q

Rate of onset

A

– Extent of capillary perfusion
– Drug vehicle
– Affected by factors that alter perfusion

28
Q

Inhalation

A
Alveolar epithelium and bronchial mucosa
Systemic effects
• Lipid-solubledrugs
– Volatile / gaseous anaesthetics
• Drugs of abuse
• Accidental poisoning
29
Q

inhalation local effects

A

– Modify structure (ipratropium)
– Particulate size (salbutamol)
– Selectivity for receptors (salbutamol)
– Rapid breakdown in circulation (fluticasone)

30
Q

Intranasal advantages

A

Easily accessible, rich vascular plexus
• Avoids hepatic first pass metabolism
• Ease ,convenience, safety

31
Q

Intranasal limitations

A

• Limited drugs suitable

– Requires concentrated drug

32
Q

Topical route

Healthy skin is a barrier

A

– Stratified, squamous epithelium
– Keratinised layer
– Sebaceous gland secretions

33
Q

local effects of topical route

A

– Corticosteroids for eczema (hydrocortisone)
– Antihistamines for insect bites (mepyramine)
– Local anaesthetics (EMLA)

34
Q

systemic effects of topical route

A

– Transdermal patches (HRT, GTN, nicotine)

– Accidental poisoning (AChEsterase insecticides)